Epstein-barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin μ, gene: Implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells

EMBO Journal

Volumn 15, Issue 2, 1996, Pages 375-382

  Jochner, Nicola ^a   Eick, Dirk ^a   Zimber Strobl, Ursula ^a   Pawlita, Michael ^b   Bornkamm, Georg W ^a   Kempkes, Bettina ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Burkitt's lymphoma; c myc; EBNA2; Epstein Barr virus; Immunoglobulin

Indexed keywords

CELL NUCLEUS ANTIGEN; ESTROGEN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN MU CHAIN; MESSENGER RNA; MUTANT PROTEIN; VIRUS ANTIGEN;

ARTICLE; BURKITT LYMPHOMA; CHROMOSOME 14; CHROMOSOME 8; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL LINE; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANTIGENS, VIRAL; BLOTTING, NORTHERN; BURKITT LYMPHOMA; CELL DIVISION; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN MU-CHAINS; KINETICS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANTIGEN, B-CELL; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0030032325     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00367.x     Document Type: Article

References (63)

1. Abbot, S.D., Rowe, M., Cadwallader, K , Ricksten, A., Gordon, J., Wang, F., Rymo, L. and Rickinson, A.B. (1990) Epstein-Barr virus nuclear antigen 2 induces expression of the virus encoded latent membrane protein. J Virol., 64, 2126-2134.
2. Albert, T., Urlbauer, B., Kohlhuber, R. Hammersen, B and Eick, D. (1994) Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene, 9, 759-763.
3. Allen, R.W , Trach, K.A. and Hoch, J.A. (1987) Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem., 262, 649-653.
4. Benjamin, D., Magrath, I.T., Maguire, R., Janus, C., Todd, H.D. and Parsons, R.G. (1982) Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. J. Immunol., 129, 1336-1342.
5. Bornkamm, G W , Hudewentz, J., Freese, U.K. and Zimber, U. (1982) Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J. Virol., 43, 952-968.
6. Bornkamm, G.W., Polack, A. and Eick, D. (1988) c-myc deregulation by chromosomal translocation in Burkitt's lymphoma In Klein, G. (ed.), Cellular Oncogene Activation. M. Dekker, Inc., New York, pp. 223-273.
7. Calender, A., Billaud, M., Aubry, J.P., Banchereau, J., Vuillaume, M. and Lenoir, G.M. (1987) Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad. Sci. USA, 84, 8060-8064.
8. Cohen, J H.M , Revillard, J.P., Magaud, J.P., Lenoir, G., Vuillaume, M., Manel, A.M., Vincent, C. and Bryon, P.A. (1987) B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. J. Natl Cancer Inst., 78, 235-242.
9. Cohen, J.L. Wang, F., Mannick, J. and Kieff, E. (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA, 86, 9558-9562.
10. Cordier, M et al. (1990) Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J. Virol., 64, 1002-1013.
11. Cordier Bussat, M., Billaud, M., Calender, A. and Lenoir, G.M. (1993) Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Int J. Cancer, 53, 153-160.
12. Dani, C , Blanchard, J.M., Piechaczyk, M., El Sabouty, S., Marty, L. and Jeanteur, J (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl Acad. Sci USA, 81, 7046-7050.
13. Eick, D. and Bornkamm, G.W. (1989) Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation. EMBO J , 8, 1965-1972.
14. Eick, D., Piechaczyk, M., Henglein, B., Blanchard, J.-M., Traub, B., Kofler, E., Wiest, S., Lenoir, G.M. and Bornkamm, G.W. (1985) Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half lives. EMBO J., 4, 3717-3725.
15. Eilers, M., Picard, D., Yamamoto, K.R. and Bishop, J.M. (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature, 340, 66-68
16. Fahraeus, R. et al. (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer, 42, 329-338.
17. Fahraeus, R., Jansson, A., Ricksten, A., Sjoblom, A and Rymo, L. (1990) Epstein-Barr virus encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl Acad. Sci. USA, 87, 7390-7394.
18. Ghosh, D. and Kieff, E. (1990) Cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site. J Virol., 64, 1855-1858.
19. κ recombination signal binding protein. Proc. Natl Acad. Sci. USA, 91, 7568-7572.
20. Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, 340, 393-397
21. κ. Science, 265, 92-95.
22. Hieter, P.A., Max, E.E., Seidman, J.G., Maizel, J.V .Jr and Leder, P (1980) Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell, 22, 197-207.
23. Hinuma, Y., Konn, M., Yamaguchi, J , Wudarski, D.J., Blakeslee, J.R., Jr and Grace, J.T., Jr (1967) Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol., 1, 1045-1051
24. Jäck, H.M. and Wabl, M. (1988) Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J., 7, 1041-1046.
25. Jin, X.W. and Speck, S.H. (1992) Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J. Virol., 66, 2846-2852.
26. κ and PU. 1. J. Virol., 69, 253-262.
27. Kanavaros, P., Jiwa, M., van der Valk, P., Walboomers, J., Horstman, A. and Meijer, C.J. (1993) Expression of the Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules m Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol., 24, 725-729.
28. Kaye, K M , Izumi, K.M. and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proc. Natl Acad. Sci. USA, 90, 9150-9154.
29. Kempkes, B., Spitkovsky, D., Jansen-Durr, P., Ellwart, J., Kremmer, E., Delecluse, H.J., Rottenberger, C., Bornkamm, G.W. and Hammerschmidt, W. (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J., 14, 88-95.
30. κ in a conditional fashion. Virology, in press
31. Kempkes, B., Zimber-Strobl, U., Eissner, G., Pawlita, M., Falk, M., Hammerschmidt, W. and Bornkamm, G.W. (1996b) FBNA2-estrogen receptor fusion proteins complement the EBNA2 deficient P3HR1 Epstein Barr virus strain in transformation of primary B cells but suppress growth of human B cell lymphoma lines. J. Gen. Virol., in press.
32. Monath, T P. and Roizman, B. (eds), Virology. Raven Press, New York, pp. 1889-1920.
33. Klein, G. (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77, 791-793.
34. Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menezes, J., Nilsson, K. and Sundstrom, C. (1974) Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad. Sci. USA, 71, 3283-3286.
35. Knutson, J.C. (1990) The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. J. Virol., 64, 2530-2536.
36. Laux, G., Dugrillon, C., Eckert, B., Adam, B., Zimber-Strobl, U. and Bornkamm, G.W. (1994a) Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J. Virol., 68, 6947-6958.
37. κ interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J., 13, 5624-5632.
38. Lenoir, G.M., Vuillaume, M. and Bonnardel, C. (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. In Lenoir, G.M., O'Conor, G.T. and Olweny, C.L.M. (eds), Burkitt's Lymphoma. A Human Cancer Model. IARC Scientific Publication, pp. 309-318.
39. Le Roux, A., Kerdiles, B , Walls, D., Dedieu, J.F. and Perricaudet, M. (1994) The Epstein-Barr virus nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology, 205, 596-602.
40. Ling, P.D., Rawlins, D R. and Hayward, S.D. (1993) The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl Acad. Sci. USA, 90, 9237-9241.
41. Magrath, I.T. et al. (1980) Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II Surface markers. J. Natl Cancer Inst., 64, 477-483.
42. Marcu, K.B., Bossone, S.A. and Patel, A.J. (1992) myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
43. Marshall, D. and Sample, C. (1995) Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J Virol , 69, 3624-3630.
44. Masucci, M.G. and Ernberg, I. (1994) Epstein-Barr virus: adaption to a life within the immune system. Trends Microbiol., 2, 125-130
45. Matsunami, N , Hamaguchi, Y., Yamamoto, Y., Kuze, K., Kangawa, K., Matsuo, H., Kawaichi, M. and Honjo, T. (1989) A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature, 342, 934-937.
46. Meitinger, C., Strobl, L.J , Marshall, G., Bornkamm, G.W and Zimber-Strobl, U. (1994) Crucial sequences within the Epstein-Barr virus TP1 - promoter for RBNA2 mediated transactivation and interaction of EBNA2 with its responsive element. J. Virol , 68, 7497-7506.
47. Miller, G. (1990) Epstein-Barr virus: biology, pathogenesis, and medical aspects In Fields, B.N., Knipe, D N., Chanock, R.M., Hirsch, M.S., Melnick, J.L., Monath, T.P. and Roizman, B. (eds). Virology. Raven Press, New York, pp. 1921-1958.
48. Picard, D , Salser, S.J. and Yamamoto, K.R. (1988) A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell, 54, 1073-1080.
49. Robertson, K.D., Barletta, J., Samid, D. and Ambinder, R.F. (1994) Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies. Curr. Top. Microbiol. Immunol., 194, 145-154.
50. κ. J. Virol., 69, 3108-3116.
51. Rochford, R. and Mosier, D.E. (1995) Differential Epstein-Barr virus expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol., 69, 150-155.
52. Rowe, D.T., Rowe, M., Evan, G.I., Wallace, I. E., Farrell, P.J. and Rickinson, A.B. (1986) Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J., 5, 2599-2607
53. Spencer, C.A. and Groudine, M. (1991) Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res., 56, 1-48.
54. Sung, N.S., Kenney, S., Gutsch, D. and Pagano, J.S. (1991) EBNA-2 transactivates a lymphoid-specific enhancer in the BamHIC promoter of Epstein-Barr virus. J. Virol., 65, 2164-2169.
55. κ) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J., 13, 5633-5638
56. Wang, F., Gregory, C.D., Rowe, M., Rickinson, A.B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T. and Kieff, E. (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl Acad. Sci. USA, 84, 3452-3456.
57. Wendel-Hansen, V., Rosén, A. and Klein, G. (1987) EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation. Int. J. Cancer, 39, 404-408.
58. Woisetschlaeger, M., Jin, X.W., Yandava, C.N., Furmanski, L.A., Strominger, J.L. and Speck, S.H. (1991) Role of the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc. Natl Acad. Sci. USA, 88, 3942-3946.
59. Young, L.S., Dawson, C W , Clark, D., Rupani, H., Busson, T., Tursz, T., Johnson, A. and Rickinson, A B. (1988) Epstean-Barr virus gene expression in nasophryngeal carcinoma. J. Gen. Virol., 69, 1051-1065.
60. Zimber, U. et al. (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology, 154, 56-66.
61. Zimber-Strobl, U., Suentzenich, K.O., Laux, G., Eick, D., Cordier, M., Calender, A., Billaud, M., Lenoir, G.M. and Bornkamm, G.W. (1991) Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol., 65, 415-423.
62. Zimber-Strobl, U., Kremmer, E., Grasser, F., Marschall, G., Laux, G. and Bornkamm, G.W. (1993) The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J., 12, 167-175.
63. κ, the homologue of Drosophila suppressor of hairless. EMBO J., 13, 4973-4982.